Multidimensional protein profiling technology and its application to human plasma proteome

被引:56
作者
Fujii, K
Nakano, T
Kawamura, T
Usui, F
Bando, Y
Wang, R
Nishimura, T
机构
[1] Tokyo Med Univ, Clin Proteome Ctr, Shinjuku Ku, Tokyo 1630203, Japan
[2] AMR Inc, Meguro Ku, Tokyo 1520031, Japan
[3] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
关键词
proteomics; human plasma; multidimensional chromatography; mu LC/MS/MS;
D O I
10.1021/pr030007q
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In clinical and diagnostic proteomics, it is essential to develop a comprehensive and robust system for proteome analysis. Although multidimensional liquid chromatography/tandem mass spectrometry (LC/ MS/MS) systems have been recently developed as powerful tools especially for identification of protein complexes, these systems still some drawbacks in their application to clinical research that requires an analysis of a large number of human samples. Therefore, in this study, we have constructed a technically simple and high throughput protein profiling system comprising a two-dimensional (2D)LC/MS/MS system which integrates both a strong cation exchange (SCX) chromatography and a muLC/ MS/MS system with micro-flowing reversed-phase chromatography. Using the muLC/MS/MS system as the second dimensional chromatography, SCX separation has been optimized as an off-line first dimensional peptide fractionation. To evaluate the performance of the constructed 2D-LC/MS/MS system, the results of detection and identification of proteins were compared using digests mixtures of 6 authentic proteins with those obtained using one-dimensional muLC/MS/MS system. The number of peptide fragments detected and the coverage of protein sequence were found to be more than double through the use of our newly built 2D-LC/MS/MS system. Furthermore, this multidimensional protein profiling system has been applied to plasma proteome in order to examine its feasibility for clinical proteomics. The experimental results revealed the identification of 174 proteins from one serum sample depleted HSA and IgG which corresponds to only 1 muL of plasma, and the total analysis run time was less than half a day, indicating a fairly high possibility of practicing clinical proteomics in a high throughput manner.
引用
收藏
页码:712 / 718
页数:7
相关论文
共 16 条
[1]   Toward a human blood serum proteome - Analysis by multidimensional separation coupled with mass spectrometry [J].
Adkins, JN ;
Varnum, SM ;
Auberry, KJ ;
Moore, RJ ;
Angell, NH ;
Smith, RD ;
Springer, DL ;
Pounds, JG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (12) :947-955
[2]   Mass spectrometry-based proteomics [J].
Aebersold, R ;
Mann, M .
NATURE, 2003, 422 (6928) :198-207
[3]   The human plasma proteome - History, character, and diagnostic prospects [J].
Anderson, NL ;
Anderson, NG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) :845-867
[4]   A 2-DIMENSIONAL GEL DATABASE OF HUMAN PLASMA-PROTEINS [J].
ANDERSON, NL ;
ANDERSON, NG .
ELECTROPHORESIS, 1991, 12 (11) :883-906
[5]   Investigation of the potential of capillary electrophoresis with off-line matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for clinical analysis: Examination of a glycoprotein factor associated with cancer cachexia [J].
Choudhary, G ;
Chakel, J ;
Hancock, W ;
Torres-Duarte, A ;
McMahon, G ;
Wainer, I .
ANALYTICAL CHEMISTRY, 1999, 71 (04) :855-859
[6]   Proteomics in 2002: A year of technical development and wide-ranging applications [J].
Figeys, D .
ANALYTICAL CHEMISTRY, 2003, 75 (12) :2891-2905
[7]  
FUJII K, 2003, P 51 ASMS C MASS SPE
[8]   Proteomic approach to apoptotic thymus maturation [J].
Kawakami, T ;
Nagata, T ;
Muraguchi, A ;
Nishimura, T .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 787 (01) :223-229
[9]  
Kawakami T, 2000, ELECTROPHORESIS, V21, P1846, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1846::AID-ELPS1846>3.3.CO
[10]  
2-9